![W. Mullally](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Mullally
Director/Board Member at
THIOGENESIS THERAPEUTICS, CORP.
Net worth: 485 694 $ as of 30/05/2026
Profile
Mr. W.
H.
Mullally is an Independent Director at Thiogenesis Therapeutics Corp.
and a President at Sectorspeak, Inc. He is on the Board of Directors at Thiogenesis Therapeutics Corp.
and Thiogenesis Therapeutics, Inc. /New/.
Mr. Mullally was previously employed as a Director-Investor Relations by Functional Technologies Corp., a Director-Investor Relations by Medicure, Inc., a Head-Pharmaceutical Sales & Marketing by iNova Pharmaceuticals (Australia) Pty Ltd. /Old/, and a Head-Pharmaceutical Sales & Marketing by Fournier Pharma SA. He also served on the board at Rozdil Capital Corp.
He received his MBA from Asper School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/05/2026 | 1,089,000 ( 2.1% ) | 485 694 $ | 30/05/2026 |
W. Mullally active positions
| Companies | Position | Start |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Director/Board Member | 02/05/2018 |
Sectorspeak, Inc.
 Sectorspeak, Inc. Sectorspeak, Inc. is an investor relations consulting firm specializing in special situation equities. The private company is based in Winnipeg, Canada. The Canadian company focuses on promoting innovative and disruptive technology firms to enhance their visibility among retail brokers, private bankers, and institutional investors. The company was founded by W. Hogan Mullally. | Founder | 29/02/2008 |
Former positions of W. Mullally
| Companies | Position | End |
|---|---|---|
| ROZDIL CAPITAL CORPORATION | Director/Board Member | 17/04/2022 |
| MEDICURE INC. | Public Communications Contact | 31/12/2007 |
Bausch & Lomb (Australia) Pty Ltd.
 Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription medicines | Sales & Marketing | 31/12/2004 |
Fournier Pharma SA
 Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 31/12/2000 |
| FUNCTIONAL TECHNOLOGIES CORP | Investor Relations Contact | - |
Training of W. Mullally
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Functional Technologies Corp.
 Functional Technologies Corp. Food: Major DiversifiedConsumer Non-Durables Develops and commercializes proprietary, yeast-based solutions in the food, beverage and healthcare industries | Consumer Non-Durables |
Fournier Pharma SA
Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes prescription medicines | Health Technology |
Asper School of Business
 Asper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Operates as capital pool company | Finance |
Sectorspeak, Inc.
Sectorspeak, Inc. Sectorspeak, Inc. is an investor relations consulting firm specializing in special situation equities. The private company is based in Winnipeg, Canada. The Canadian company focuses on promoting innovative and disruptive technology firms to enhance their visibility among retail brokers, private bankers, and institutional investors. The company was founded by W. Hogan Mullally. | |
Thiogenesis Therapeutics Corp.
 Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
- Stock Market
- Insiders
- W. Mullally
